{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T22:57:34Z","timestamp":1790895454612,"version":"4.1.0"},"reference-count":73,"publisher":"Georg Thieme Verlag KG","issue":"02","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Semin Liver Dis"],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:p>Extracorporeal liver support (ECLS) systems provide detoxification and synthetic function support for patients with acute liver failure and acute-on-chronic liver failure to achieve spontaneous recovery of hepatic function or act as a bridge to liver transplant. Artificial ECLS (A-ECLS) systems use diffusion, convection, and adsorption to remove toxins and modulate inflammation, improving biochemical and hemodynamic parameters. Despite the development of multiple A-ECLS devices, only plasma exchange has demonstrated a survival benefit in acute liver failure, while other devices require further study. Studies in bioartificial ECLS (B-ECLS) systems have utilized human or porcine hepatocytes in the extracorporeal circuit to serve the hepatic functions of both detoxification and synthetic function, but there is insufficient evidence to support their use currently. Future studies should prioritize evaluating combination strategies that integrate A-ECLS and B-ECLS systems and should define efficacy by expanding study endpoints beyond traditional transplant-free survival endpoints to include both overall survival and transplant-related outcomes. In conclusion, current and future advances in ECLS may provide valuable therapeutic options in the management of patients with liver failure.<\/jats:p>","DOI":"10.1055\/a-2926-5335","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T23:42:51Z","timestamp":1785368571000},"page":"171-182","source":"Crossref","is-referenced-by-count":0,"title":["Advances in Extracorporeal Liver Support"],"prefix":"10.1055","volume":"46","author":[{"given":"Kathryn","family":"Thompson","sequence":"additional","affiliation":[{"name":"Emory University School of Medicine, Georgia, United States","place":["Atlanta"],"department":["Department of Medicine"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hima","family":"Veeramachaneni","sequence":"additional","affiliation":[{"name":"Emory University School of Medicine, Georgia, United States","place":["Atlanta"],"department":["Department of Medicine, Division of Digestive Diseases-Transplant Hepatology"]},{"name":"Emory University School of Medicine, Georgia, United States","place":["Atlanta"],"department":["Department of Medicine, Division of Pulmonary and Critical Care Medicine"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6730-4242","authenticated-orcid":false,"given":"Ram","family":"Subramanian","sequence":"additional","affiliation":[{"name":"Emory University School of Medicine, Georgia, United States","place":["Atlanta"],"department":["Department of Medicine, Division of Digestive Diseases-Transplant Hepatology"]},{"name":"Emory University School of Medicine, Georgia, United States","place":["Atlanta"],"department":["Department of Medicine, Division of Pulmonary and Critical Care Medicine"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2026,8,6]]},"reference":[{"issue":"06","key":"ref1","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1002\/lt.24396","article-title":"Extracorporeal liver support devices for listed patients","volume":"22","author":"K C Lee","year":"2016","journal-title":"Liver Transpl"},{"issue":"04","key":"ref2","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1586\/17434440.2016.1154455","article-title":"Extracorporeal support for patients with acute and acute on chronic liver failure","volume":"13","author":"J Aron","year":"2016","journal-title":"Expert Rev Med Devices"},{"issue":"01","key":"ref3","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ccc.2018.08.003","article-title":"Extracorporeal devices","volume":"35","author":"P A Kandiah","year":"2019","journal-title":"Crit Care Clin"},{"issue":"05","key":"ref4","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1002\/hep.20703","article-title":"AASLD position paper: the management of acute liver failure","volume":"41","author":"J Polson","year":"2005","journal-title":"Hepatology"},{"issue":"26","key":"ref5","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1056\/NEJMra1208937","article-title":"Acute liver failure","volume":"369","author":"W Bernal","year":"2013","journal-title":"N Engl J Med"},{"issue":"05","key":"ref6","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1097\/CCM.0000000000005824","article-title":"Guidelines for the management of adult acute and acute-on-chronic liver failure in the ICU: neurology, peri-transplant medicine, infectious disease, and gastroenterology considerations","volume":"51","author":"R Nanchal","year":"2023","journal-title":"Crit Care Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S0140-6736(24)00693-7","article-title":"Acute liver failure","volume":"404","author":"R Maiwall","year":"2024","journal-title":"Lancet"},{"issue":"02","key":"ref8","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jhep.2023.04.021","article-title":"EASL Clinical Practice Guidelines on acute-on-chronic liver failure","volume":"79","author":"European Association for the Study of the Liver","year":"2023","journal-title":"J Hepatol"},{"issue":"06","key":"ref9","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1097\/HEP.0000000000000671","article-title":"AASLD Practice Guidance on Acute-on-chronic liver failure and the management of critically ill patients with cirrhosis","volume":"79","author":"C J Karvellas","year":"2024","journal-title":"Hepatology"},{"issue":"03","key":"ref10","doi-asserted-by":"crossref","first-page":"e15659","DOI":"10.1111\/liv.15659","article-title":"Management of the acute on chronic liver failure in the intensive care unit","volume":"45","author":"C J Karvellas","year":"2025","journal-title":"Liver Int"},{"issue":"03","key":"ref11","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.ccc.2016.03.003","article-title":"Current evidence for extracorporeal liver support systems in acute liver failure and acute-on-chronic liver failure","volume":"32","author":"C J Karvellas","year":"2016","journal-title":"Crit Care Clin"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"101964","DOI":"10.1016\/j.bpg.2024.101964","article-title":"Liver assistive devices in acute liver failure: current use and future directions","volume":"73","author":"V Dong","year":"2024","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"S 02","key":"ref13","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1002\/lt.23506","article-title":"Bridging the gap: advances in artificial liver support","volume":"18","author":"S L Nyberg","year":"2012","journal-title":"Liver Transpl"},{"issue":"09","key":"ref14","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1111\/j.1525-1594.1993.tb00635.x","article-title":"Dialysis against a recycled albumin solution enables the removal of albumin-bound toxins","volume":"17","author":"J Stange","year":"1993","journal-title":"Artif Organs"},{"issue":"04","key":"ref15","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1046\/j.1525-1594.1999.06122.x","article-title":"Molecular adsorbent recycling system (MARS): clinical results of a new membrane-based blood purification system for bioartificial liver support","volume":"23","author":"J Stange","year":"1999","journal-title":"Artif Organs"},{"issue":"03","key":"ref16","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/cc5922","article-title":"Bench-to-bedside review: current evidence for extracorporeal albumin dialysis systems in liver failure","volume":"11","author":"C J Karvellas","year":"2007","journal-title":"Crit Care"},{"issue":"03","key":"ref17","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1053\/lv.2000.6355","article-title":"Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial","volume":"6","author":"S R Mitzner","year":"2000","journal-title":"Liver Transpl"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1053\/jhep.2002.36130","article-title":"Albumin dialysis in cirrhosis with superimposed acute liver injury: a prospective, controlled study","volume":"36","author":"U Heemann","year":"2002","journal-title":"Hepatology"},{"issue":"06","key":"ref19","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1002\/hep.21930","article-title":"Randomized controlled study of extracorporeal albumin dialysis for hepatic encephalopathy in advanced cirrhosis","volume":"46","author":"T I Hassanein","year":"2007","journal-title":"Hepatology"},{"issue":"03","key":"ref20","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1002\/hep.26185","article-title":"Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trial","volume":"57","author":"R Ba\u00f1ares","year":"2013","journal-title":"Hepatology"},{"issue":"03","key":"ref21","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1053\/jlts.2003.50051","article-title":"Systemic hemodynamic effects of treatment with the molecular adsorbents recirculating system in patients with hyperacute liver failure: a prospective controlled trial","volume":"9","author":"L E Schmidt","year":"2003","journal-title":"Liver Transpl"},{"issue":"04","key":"ref22","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/01.MAT.0000131251.88146.CD","article-title":"First use of the Molecular Adsorbent Recirculating System technique on patients with hypoxic liver failure after cardiogenic shock","volume":"50","author":"A El Banayosy","year":"2004","journal-title":"ASAIO J"},{"issue":"08","key":"ref23","doi-asserted-by":"crossref","first-page":"522","DOI":"10.7326\/0003-4819-159-8-201310150-00005","article-title":"Albumin dialysis with a noncell artificial liver support device in patients with acute liver failure: a randomized, controlled trial","volume":"159","author":"F Saliba","year":"2013","journal-title":"Ann Intern Med"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13054-015-1159-3","article-title":"Molecular adsorbent recirculating system and single-pass albumin dialysis in liver failure\u2013a prospective, randomised crossover study","volume":"20","author":"C Sponholz","year":"2016","journal-title":"Crit Care"},{"issue":"S 02","key":"ref25","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1034\/j.1600-0676.2002.00007.x","article-title":"Albumin dialysis: single pass vs. recirculation (MARS)","volume":"22","author":"P Peszynski","year":"2002","journal-title":"Liver"},{"issue":"05","key":"ref26","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1744-9987.2009.00760.x","article-title":"Albumin dialysis in liver failure: comparison of molecular adsorbent recirculating system and single pass albumin dialysis\u2013a retrospective analysis","volume":"13","author":"A Kortgen","year":"2009","journal-title":"Ther Apher Dial"},{"issue":"03","key":"ref27","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1159\/000227280","article-title":"A case-control study of single-pass albumin dialysis for acetaminophen-induced acute liver failure","volume":"28","author":"C J Karvellas","year":"2009","journal-title":"Blood Purif"},{"issue":"04","key":"ref28","doi-asserted-by":"crossref","first-page":"R108","DOI":"10.1186\/cc4985","article-title":"Effect of the molecular adsorbent recirculating system and Prometheus devices on systemic haemodynamics and vasoactive agents in patients with acute-on-chronic alcoholic liver failure","volume":"10","author":"W Laleman","year":"2006","journal-title":"Crit Care"},{"issue":"04","key":"ref29","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1053\/j.gastro.2011.12.056","article-title":"Effects of fractionated plasma separation and adsorption on survival in patients with acute-on-chronic liver failure","volume":"142","author":"A Kribben","year":"2012","journal-title":"Gastroenterology"},{"issue":"08","key":"ref30","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1016\/j.transproceed.2009.08.024","article-title":"Results of treatment of acute liver failure patients with use of the Prometheus FPSA system","volume":"41","author":"M Grodzicki","year":"2009","journal-title":"Transplant Proc"},{"issue":"02","key":"ref31","first-page":"171","article-title":"Treatment of Amanita phalloides intoxication by fractionated plasma separation and adsorption (Prometheus\u00ae)","volume":"21","author":"D Bergis","year":"2012","journal-title":"J Gastrointestin Liver Dis"},{"issue":"04","key":"ref32","first-page":"230","article-title":"Prometheus therapy for the treatment of acute liver failure in patients after cardiac surgery","volume":"14","author":"E Komardina","year":"2017","journal-title":"Kardiochir Torakochirurgia Pol"},{"issue":"11","key":"ref33","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1177\/039139889201501110","article-title":"High volume plasma exchange in fulminant hepatic failure","volume":"15","author":"J Kondrup","year":"1992","journal-title":"Int J Artif Organs"},{"issue":"01","key":"ref34","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1159\/000014407","article-title":"Effect of plasma exchange on serum tissue inhibitor of metalloproteinase 1 and cytokine concentrations in patients with fulminant hepatitis","volume":"18","author":"T Nakamura","year":"2000","journal-title":"Blood Purif"},{"issue":"09","key":"ref35","first-page":"887","article-title":"Systemic vascular resistance during high-volume plasmapheresis in patients with fulminant hepatic failure: relationship with oxygen consumption","volume":"7","author":"F S Larsen","year":"1995","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"03","key":"ref36","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/00042737-199603000-00014","article-title":"Cerebral blood flow, oxygen metabolism and transcranial Doppler sonography during high-volume plasmapheresis in fulminant hepatic failure","volume":"8","author":"F S Larsen","year":"1996","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"01","key":"ref37","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jhep.2015.08.018","article-title":"High-volume plasma exchange in patients with acute liver failure: an open randomised controlled trial","volume":"64","author":"F S Larsen","year":"2016","journal-title":"J Hepatol"},{"issue":"04","key":"ref38","doi-asserted-by":"crossref","first-page":"e831","DOI":"10.1016\/j.cgh.2021.01.036","article-title":"Standard-volume plasma exchange improves outcomes in patients with acute liver failure: a randomized controlled trial","volume":"20","author":"R Maiwall","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"03","key":"ref39","doi-asserted-by":"crossref","first-page":"101354","DOI":"10.1016\/j.jceh.2024.101354","article-title":"Standard-volume is as effective as high-volume plasma exchange for patients with acute liver failure","volume":"14","author":"A V Kulkarni","year":"2024","journal-title":"J Clin Exp Hepatol"},{"issue":"02","key":"ref40","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1002\/hep.31710","article-title":"Combined high-dose continuous renal replacement therapy and plasma exchange in the management of severe multiorgan system dysfunction associated with acute liver failure","volume":"74","author":"H Veeramachaneni","year":"2021","journal-title":"Hepatology"},{"issue":"02","key":"ref41","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/hep.29488","article-title":"Continuous renal replacement therapy is associated with reduced serum ammonia levels and mortality in acute liver failure","volume":"67","author":"F S Cardoso","year":"2018","journal-title":"Hepatology"},{"issue":"01","key":"ref42","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.transci.2008.11.006","article-title":"Efficacy of high-flow dialysate continuous hemodiafiltration in the treatment of fulminant hepatic failure","volume":"40","author":"T Yokoi","year":"2009","journal-title":"Transfus Apher Sci"},{"issue":"05","key":"ref43","doi-asserted-by":"crossref","first-page":"e70018","DOI":"10.1111\/liv.70018","article-title":"Therapeutic plasma exchange in patients with acute-on-chronic liver failure improves survival-an updated meta-analysis","volume":"45","author":"S E Kumar","year":"2025","journal-title":"Liver Int"},{"issue":"01","key":"ref44","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jhep.2023.03.013","article-title":"Randomized, controlled clinical trial of the DIALIVE liver dialysis device versus standard of care in patients with acute-on- chronic liver failure","volume":"79","author":"B Agarwal","year":"2023","journal-title":"J Hepatol"},{"issue":"06","key":"ref45","first-page":"1446","article-title":"Pilot-controlled trial of the extracorporeal liver assist device in acute liver failure","volume":"24","author":"A J Ellis","year":"1996","journal-title":"Hepatology"},{"issue":"03","key":"ref46","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/lt.24986","article-title":"Extracorporeal cellular therapy (ELAD) in severe alcoholic hepatitis: a multinational, prospective, controlled, randomized trial","volume":"24","author":"J Thompson","year":"2018","journal-title":"Liver Transpl"},{"issue":"05","key":"ref47","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1097\/01.sla.0000124298.74199.e5","article-title":"Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure","volume":"239","author":"A A Demetriou","year":"2004","journal-title":"Ann Surg"},{"issue":"02","key":"ref48","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/00007890-200201270-00019","article-title":"Neurological improvement during bioartificial liver sessions in patients with acute liver failure awaiting transplantation","volume":"73","author":"D Samuel","year":"2002","journal-title":"Transplantation"},{"issue":"05","key":"ref49","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/00002480-200109000-00015","article-title":"Safety observations in phase I clinical evaluation of the Excorp Medical Bioartificial Liver Support System after the first four patients","volume":"47","author":"G V Mazariegos","year":"2001","journal-title":"ASAIO J"},{"issue":"08","key":"ref50","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1046\/j.1525-1594.2002.06931_1.x","article-title":"Modular extracorporeal liver support","volume":"26","author":"I M Sauer","year":"2002","journal-title":"Artif Organs"},{"issue":"05","key":"ref51","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1034\/j.1399-3089.2003.00062.x","article-title":"Clinical extracorporeal hybrid liver support\u2013phase I study with primary porcine liver cells","volume":"10","author":"I M Sauer","year":"2003","journal-title":"Xenotransplantation"},{"issue":"10","key":"ref52","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1177\/039139880202501009","article-title":"Phase I clinical trial with the AMC-bioartificial liver","volume":"25","author":"M P van de Kerkhove","year":"2002","journal-title":"Int J Artif Organs"},{"issue":"03","key":"ref53","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1177\/039139880202500305","article-title":"Early experiences with a porcine hepatocyte-based bioartificial liver in acute hepatic failure patients","volume":"25","author":"E Morsiani","year":"2002","journal-title":"Int J Artif Organs"},{"issue":"04","key":"ref54","doi-asserted-by":"crossref","first-page":"100203","DOI":"10.1016\/j.iliver.2025.100203","article-title":"Efficacy of DPMAS combined with PE in improving survival outcomes of patients with acute hepatitis E-induced liver failure: a retrospective cohort analysis","volume":"4","author":"R Tang","year":"2025","journal-title":"ILIVER"},{"issue":"04","key":"ref55","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/jca.21690","article-title":"Therapeutic effect of double plasma molecular adsorption system and sequential half-dose plasma exchange in patients with HBV-related acute-on-chronic liver failure","volume":"34","author":"J Yao","year":"2019","journal-title":"J Clin Apher"},{"issue":"12","key":"ref56","doi-asserted-by":"crossref","first-page":"e047690","DOI":"10.1136\/bmjopen-2020-047690","article-title":"Efficacy and safety of combination treatment of double plasma molecular adsorption system and low volume plasma exchange for patients with hepatitis B virus related acute-on-chronic liver failure: a multicentre randomised controlled clinical trial","volume":"11","author":"W Xu","year":"2021","journal-title":"BMJ Open"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1159\/000102127","article-title":"Continuous hemodiafiltration with cytokine-adsorbing hemofilter in the treatment of severe sepsis and septic shock","volume":"156","author":"H Hirasawa","year":"2007","journal-title":"Contrib Nephrol"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2119\/2007-00108.Nakada","article-title":"Continuous hemodiafiltration with PMMA Hemofilter in the treatment of patients with septic shock","volume":"14","author":"T A Nakada","year":"2008","journal-title":"Mol Med"},{"issue":"01","key":"ref59","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s13613-025-01499-z","article-title":"Endotoxin removal by the OXIRIS filter for cardiogenic shock requiring veno-arterial extra-corporeal life support: the ECMORIX randomized controlled trial","volume":"15","author":"M Nguyen","year":"2025","journal-title":"Ann Intensive Care"},{"issue":"01","key":"ref60","doi-asserted-by":"crossref","first-page":"19645","DOI":"10.1038\/s41598-024-70522-3","article-title":"Simultaneous removal of endotoxins, inflammatory mediators and uremic toxins in ICU patients with septic shock: a retrospective cohort study","volume":"14","author":"B E Theisen","year":"2024","journal-title":"Sci Rep"},{"issue":"06","key":"ref61","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.3390\/jcm12062258","article-title":"Artificial liver support with CytoSorb and MARS in liver failure: a retrospective propensity matched analysis","volume":"12","author":"M Popescu","year":"2023","journal-title":"J Clin Med"},{"issue":"12","key":"ref62","doi-asserted-by":"crossref","first-page":"e70420","DOI":"10.1111\/liv.70420","article-title":"Feasibility and safety of Cytosorb application in patients with acute liver failure","volume":"45","author":"P Haselwanter","year":"2025","journal-title":"Liver Int"},{"issue":"01","key":"ref63","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1186\/s12882-025-04342-6","article-title":"Artificial liver support with Cytosorb and continuous veno-venous hemodiafiltration versus advanced organ support (ADVOS) for critically ill patients with hyperbilirubinemia and acute-on-chronic liver failure (ACLF)","volume":"26","author":"K Sch\u00f6nfelder","year":"2025","journal-title":"BMC Nephrol"},{"issue":"01","key":"ref64","doi-asserted-by":"crossref","first-page":"11309","DOI":"10.1038\/s41598-024-61658-3","article-title":"Use of the CytoSorb adsorber in patients with acute-on-chronic liver failure","volume":"14","author":"P Haselwanter","year":"2024","journal-title":"Sci Rep"},{"issue":"07","key":"ref65","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1016\/j.transproceed.2019.01.167","article-title":"Impact of cytokine adsorption treatment in liver failure","volume":"51","author":"U Acar","year":"2019","journal-title":"Transplant Proc"},{"issue":"01","key":"ref66","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3390\/biomedicines12010067","article-title":"Hemoadsorption therapy for critically ill patients with acute liver dysfunction: a meta-analysis and systematic review","volume":"12","author":"C Turan","year":"2023","journal-title":"Biomedicines"},{"issue":"01","key":"ref67","doi-asserted-by":"crossref","first-page":"10190","DOI":"10.1038\/s41598-021-89712-4","article-title":"Successful elimination of bilirubin in critically ill patients with acute liver dysfunction using a cytokine adsorber and albumin dialysis: a pilot study","volume":"11","author":"C Scharf","year":"2021","journal-title":"Sci Rep"},{"issue":"08","key":"ref68","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/j.ajt.2025.06.022","article-title":"Extracorporeal liver support with a porcine liver: The United States Food and Drug Administration approves the first trial","volume":"25","author":"L C Pullen","year":"2025","journal-title":"Am J Transplant"},{"issue":"03","key":"ref70","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S1499-3872(12)60155-6","article-title":"Key challenges to the development of extracorporeal bioartificial liver support systems","volume":"11","author":"L F Zhao","year":"2012","journal-title":"Hepatobiliary Pancreat Dis Int"},{"issue":"01","key":"ref71","doi-asserted-by":"crossref","first-page":"e227","DOI":"10.1002\/term.2385","article-title":"Challenges on the road to a multicellular bioartificial liver","volume":"12","author":"V Starokozhko","year":"2018","journal-title":"J Tissue Eng Regen Med"},{"issue":"04","key":"ref72","first-page":"43","article-title":"Extracorporeal liver support: an updated review of mechanisms and current literature","volume":"12","author":"A Nguyen","year":"2022","journal-title":"J Community Hosp Intern Med Perspect"},{"issue":"S 01","key":"ref73","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1191\/0267659104pf716oa","article-title":"The role of the Molecular Adsorbents Recirculating System (MARS) in the management of liver failure","volume":"19","author":"S Sen","year":"2004","journal-title":"Perfusion"},{"issue":"01","key":"ref74","doi-asserted-by":"crossref","first-page":"103178","DOI":"10.1016\/j.jceh.2025.103178","article-title":"Therapeutic plasma exchange in patients with acute liver failure: a pilot randomized controlled trial","volume":"16","author":"S Swaroop","year":"2026","journal-title":"J Clin Exp Hepatol"}],"container-title":["Seminars in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2926-5335.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T22:40:04Z","timestamp":1790894404000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2926-5335"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":73,"journal-issue":{"issue":"02","published-online":{"date-parts":[[2026,10,1]]},"published-print":{"date-parts":[[2026,6]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2926-5335","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0272-8087","1098-8971"],"issn-type":[{"value":"0272-8087","type":"print"},{"value":"1098-8971","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,7,29]]},"published":{"date-parts":[[2026,6]]}}}